Integral Diagnostics Limited (ASX:IDX)
Australia flag Australia · Delayed Price · Currency is AUD
2.140
+0.020 (0.94%)
Oct 7, 2026, 4:10 PM AEST

Integral Diagnostics Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, Integral Diagnostics stock has a consensus rating of "Buy" and an average price target of $2.99. The average 1-year stock price forecast is 39.72% higher than the current stock price, while the lowest is $2.24 (+4.67%) and the highest is $3.70 (+72.90%).

Price Target: $2.99 (+39.72%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$2.24$2.99$3.15$3.70
Change+4.67%+39.72%+47.20%+72.90%

Analyst Ratings

The average analyst rating for Integral Diagnostics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingApr '26May '26Jun '26Jul '26Aug '26Sep '26
Strong Buy888888
Buy334443
Hold011122
Sell000000
Strong Sell100000
Total121213131413

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
RBC Capital
RBC Capital
Buy
Maintains
$3.20
BuyMaintains$3.20+49.53%Sep 15, 2026
Morgan Stanley
Morgan Stanley
Buy
Maintains
$3.70
BuyMaintains$3.70+72.90%Sep 8, 2026
Jefferies
Jefferies
Buy
Maintains
$3.50 → $3.30
BuyMaintains$3.50 → $3.30+54.21%Aug 27, 2026
Jarden
Jarden
Buy
Maintains
$2.95
BuyMaintains$2.95+37.85%Aug 27, 2026
Bell Potter
Bell Potter
Buy
Maintains
$3.60 → $3.15
BuyMaintains$3.60 → $3.15+47.20%Aug 26, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
837.19M
from 788.62M
Increased by 6.16%
Revenue Next Year
884.33M
from 837.19M
Increased by 5.63%
EPS This Year
0.13
from 0.13
Increased by 6.22%
EPS Next Year
0.16
from 0.13
Increased by 16.05%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingJun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2026Jun 30, 2027
Revenue
360.93M440.76M469.70M627.22M788.62M837.19M
Revenue Growth
2.92%22.12%6.57%33.54%25.73%6.16%
Gross Profit
122.10M142.43M151.90M195.98M243.36M284.65M
Gross Margin
33.83%32.31%32.34%31.25%30.86%34.00%
Operating Income
38.62M38.47M42.17M56.80M73.84M101.52M
Net Income
14.60M25.04M-60.70M2.69M21.93M44.09M
EPS
----0.130.13
EPS Growth
----23.53%6.22%
Forward PE
17.4225.9927.6720.3213.7715.99
Dividend / Share
0.070.060.060.070.090.09
Dividend Growth
-44.00%-14.29%-3.33%12.07%43.08%-0.38%
Free Cash Flow
----45.60M62.29M
No. Analysts
-----12
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Revenue202720282029
High846.0M
Avg837.2M
Low831.4M

Revenue Growth

Revenue Growth202720282029
High
7.3%
Avg
6.2%
Low
5.4%

EPS Forecast

EPS202720282029
High0.14
Avg0.13
Low0.13

EPS Growth

EPS Growth202720282029
High
11.9%
Avg
6.2%
Low
1.4%